Non-small cell lung cancer – mutations, targeted and combination therapy

by Justyna Kutkowska, Irena Porębska, Andrzej Rapak
Published 2017-05-01

Serum and Whole Blood Cu and Zn Status in Predicting Mortality in Lung Cancer Patients

by Katarzyna Zabłocka-Słowińska, Anna Prescha, Sylwia Płaczkowska, Irena Porębska, Monika Kosacka, Konrad Pawełczyk
Published 2021-12-01

Systemic redox status in lung cancer patients is related to altered glucose metabolism.

by Katarzyna Zabłocka-Słowińska, Sylwia Płaczkowska, Anna Prescha, Konrad Pawełczyk, Monika Kosacka, Irena Porębska, Halina Grajeta
Published 2018-01-01

Oxidative stress in lung cancer patients is associated with altered serum markers of lipid metabolism.

by Katarzyna Zabłocka-Słowińska, Sylwia Płaczkowska, Katarzyna Skórska, Anna Prescha, Konrad Pawełczyk, Irena Porębska, Monika Kosacka, Halina Grajeta
Published 2019-01-01

Total antioxidant status in lung cancer is associated with levels of endogenous antioxidants and disease stage rather than lifestyle factors – preliminary study

by Katarzyna Zabłocka-Słowińska, Irena Porębska, Marcin Gołecki, Monika Kosacka, Konrad Pawełczyk, Lilla Pawlik-Sobecka, Katarzyna Zarębska, Halina Grajeta
Published 2016-09-01

Polymorphisms of Antigen-Presenting Machinery Genes in Non-Small Cell Lung Cancer: Different Impact on Disease Risk and Clinical Parameters in Smokers and Never-Smokers

by Andrzej Wiśniewski, Maciej Sobczyński, Konrad Pawełczyk, Irena Porębska, Monika Jasek, Marta Wagner, Wanda Niepiekło-Miniewska, Aneta Kowal, Joanna Dubis, Natalia Jędruchniewicz, Piotr Kuśnierczyk
Published 2021-05-01